NetworkNewsWire.com

An innovative potential treatment for hepatic encephalopathy created by Ocera Therapeutics, Inc. (NASDAQ:OCRX) is a unique product on an under-served market, and if clinical trials are successful, it could become a major source of success and profitability for the company, according to an Aegis Capital Corp. report (http://nnw.fm/cNkZ1) released on December 8. The report reiterates a 'Buy' rating for Ocera and recommends a higher stock price target of $8, compared to the $2.1 at the time of the analysis.

Nano Dimension Ltd. (NASDAQ:NNDM) is the holding company for Nano Dimension Technology Ltd., a company in the business of researching, developing, and manufacturing three-dimensional (3D) printers for printed circuit boards (PCBs). The company also develops nano ink materials and other products for electronics. NNDM has the vision of revolutionizing the way electronics are made with 3D printing by using 3D printers for multilayer PCBs, along with advanced nanotechnology-based conductive and dielectric inks.

How does a start-up venture capital-backed company grow its revenues to nearly a billion dollars in the global spine industry in less than two decades? By developing a competitive advantage in Speed of Innovation(R) and Absolute Responsiveness(R), two concepts that have made NuVasive, Inc. (NASDAQ:NUVA) the number three company in the spine industry with over 90 products in its portfolio, including lumbar, thoracic, and cervical applications; neuromonitoring services; and biologics solutions.

One of the biggest questions after President-elect Donald Trump is officially sworn in is what will happen with the controversial Affordable Care Act, also known as Obamacare - a law intended to make health insurance more affordable for medium and low-income Americans. Trump himself has often pledged to repeal and replace the law when he takes office, while his pick for Secretary of Health, Georgia Rep. Tom Price is a fierce opponent of the plan and sponsored a reconciliation bill last year designed to cut funding for the program. The bill, which was passed by both houses of Congress but was vetoed by President Barack Obama, would have eliminated cost-sharing subsidies, premium tax credits and federal funding for Medicaid, as well as ended tax penalties for people who failed to maintain health insurance.

With the recent EPA approval (http://nnw.fm/X82tJ) of SenesTech's (NASDAQ:SNES) ContraPest(R), a humane, liquid contraceptive bait designed to address unwieldy rodent populations, there now appears to be an impending end to the unsustainable rodenticide paradigm that has persisted for decades due to a lack of other options. SenesTech is Arizona's newest public company, as of its December 8 IPO (http://nnw.fm/m4xhG) on the NASDAQ Capital Market. The publicly traded stock gives investors a big opportunity to get in on the ground floor behind a proprietary and potentially paradigm-shattering technology that is not only safe to humans, but also drastically less impactful to the environment.

Before the opening bell, Net Element, Inc. (NASDAQ:NETE), through subsidiary PayOnline, announced the launch of a new payment acceptance module for Telegram, a popular cloud-based mobile and desktop instant messenger application. As of February 2016, Telegram boasted roughly 100 million monthly users generating about 15 billion secure and encrypted messages each day. PayOnline will look to widen the usability of Telegram through the introduction of an integrated payment acceptance module for use with the high-volume insurance industry. The company's payments module is currently available for VTB Insurance, a leading insurance provider operating in Russia.

Social Reality, Inc. (NASDAQ:SRAX) is an Internet advertising company focused on providing tools that automate the digital advertising market. The company has developed three core platforms to deliver a complete set of marketing tools and services that create new and measurable opportunities for brands, agencies and publishers to target, reach and monetize their audiences.

Nano Dimension Ltd. (NASDAQ:NNDM) is an Israel-based technology company focused on the development of advanced 3D printed electronics systems and advanced additive manufacturing. Since its founding in 2012, the company has successfully established a position at the forefront of the rapidly expanding 3D printing market by relying on a combination of three advanced technologies, including the 3D inkjet, proprietary 3D software and innovative nanomaterials. Among its most well-known offerings, Nano Dimension developed the first 3D printer on the market dedicated to the creation of multi-layer printed circuit boards (PCBs), as well as a series of advanced nanotechnology-based conductive and dielectric inks which are complementary products for 3D printers.

MediWound Ltd. (NASDAQ:MDWD) is a biopharmaceutical company in the business of developing, manufacturing, and globally commercializing products that treat severe burns and wounds. In 2012, MediWound's innovative drug, NexoBrid(TM), a burn and wound eschar removal agent, was approved by the European Medicines Agency (EMA) via a centralized procedure. The drug was given orphan indication for removal of dead and damaged skin in adults with burns that are deep partial and full thickness thermal burns.

Daktronics, Inc. (NASDAQ:DAKT), a company that designs, manufactures, and sells electronic display systems and related products on a global scale, has been the topic of several reports since the company announced breaking into a new 52-week high on November 25, 2016. Equities.com (http://nnw.fm/Yr4Hm) announced shares for the company reached a peak of $10.78, closing at $10.64 after opening at $10.46, a move of over 2% is just one day.